191 related articles for article (PubMed ID: 21597544)
21. Hormonal strategies of the menopause.
Damewood MD
Md Med J; 1997 Sep; 46(8):415-8. PubMed ID: 9294948
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy: controversies, pros and cons.
Warren MP; Halpert S
Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):317-32. PubMed ID: 15261840
[TBL] [Abstract][Full Text] [Related]
23. If not hormones--then what?
Murkies A
Aust Fam Physician; 2004 Nov; 33(11):895-9. PubMed ID: 15584327
[TBL] [Abstract][Full Text] [Related]
24. Menopause, HRT and menopausal symptoms.
Kenemans P
J Epidemiol Biostat; 1999; 4(3):141-6; discussion 146-53. PubMed ID: 10695956
[TBL] [Abstract][Full Text] [Related]
25. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
26. Counseling patients about hormone therapy and alternatives for menopausal symptoms.
Hill DA; Hill SR
Am Fam Physician; 2010 Oct; 82(7):801-7. PubMed ID: 20879703
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
28. Understanding the menopausal experiences of professional women.
Simon JA; Reape KZ
Menopause; 2009; 16(1):73-6. PubMed ID: 18779760
[TBL] [Abstract][Full Text] [Related]
29. Risk perception in women: a focus on menopause.
Deeks A; Zoungas S; Teede H
Menopause; 2008; 15(2):304-9. PubMed ID: 18090036
[TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
31. Management of menopause in women with breast cancer.
Brzezinski A
Isr J Med Sci; 1995; 31(2-3):163-8. PubMed ID: 7744587
[TBL] [Abstract][Full Text] [Related]
32. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
33. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Johansen OE; Qvigstad E
Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
[TBL] [Abstract][Full Text] [Related]
34. Prevention for the older woman. A practical guide to hormone replacement therapy and urogynecologic health.
Messinger-Rapport BJ; Thacker HL
Geriatrics; 2001 Sep; 56(9):32-4, 37-8, 40-2. PubMed ID: 11582972
[TBL] [Abstract][Full Text] [Related]
35. Estrogen with and without progestin: benefits and risks of short-term use.
LaCroix AZ
Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
[TBL] [Abstract][Full Text] [Related]
36. Vasomotor symptoms in menopause: where we've been and where we're going.
Pinkerton JV; Zion AS
J Womens Health (Larchmt); 2006 Mar; 15(2):135-45. PubMed ID: 16536677
[TBL] [Abstract][Full Text] [Related]
37. Management of menopause in women with breast cancer.
Vincent AJ
Climacteric; 2015 Oct; 18(5):690-701. PubMed ID: 25536007
[TBL] [Abstract][Full Text] [Related]
38. A risk-benefit assessment of estrogen therapy in postmenopausal women.
Cust MP; Gangar KF; Hillard TC; Whitehead MI
Drug Saf; 1990; 5(5):345-58. PubMed ID: 2222868
[TBL] [Abstract][Full Text] [Related]
39. Menopause.
Davis SR; Lambrinoudaki I; Lumsden M; Mishra GD; Pal L; Rees M; Santoro N; Simoncini T
Nat Rev Dis Primers; 2015 Apr; 1():15004. PubMed ID: 27188659
[TBL] [Abstract][Full Text] [Related]
40. What works? Evidence for lifestyle and nonprescription therapies in menopause.
Warnecke E
Aust Fam Physician; 2011 May; 40(5):286-9. PubMed ID: 21597545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
